Miller L, Murray K, Branch E, Thakarar K
J Maine Med Cent. 2024; 6(1).
PMID: 39118865
PMC: 11309026.
DOI: 10.46804/2641-2225.1153.
Heo M, Beachler T, Sivaraj L, Tsai H, Chea A, Patel A
Subst Abuse Treat Prev Policy. 2023; 18(1):23.
PMID: 37076898
PMC: 10114389.
DOI: 10.1186/s13011-023-00532-3.
Allen S, Schneider K, Morris M, Rouhani S, Harris S, Saloner B
Harm Reduct J. 2023; 20(1):18.
PMID: 36793041
PMC: 9930060.
DOI: 10.1186/s12954-023-00746-5.
Allen S, Danforth S, Grieb S, Glick J, Harris S, Tomko C
Harm Reduct J. 2022; 19(1):109.
PMID: 36180853
PMC: 9526275.
DOI: 10.1186/s12954-022-00684-8.
Allen S, White R, ORourke A, Schneider K, Weir B, Lucas G
AIDS Behav. 2021; 25(10):3377-3385.
PMID: 33886011
DOI: 10.1007/s10461-021-03247-3.
State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.
Fernandez-Vina M, Prood N, Herpolsheimer A, Waimberg J, Burris S
Public Health Rep. 2020; 135(1_suppl):128S-137S.
PMID: 32735195
PMC: 7407055.
DOI: 10.1177/0033354920921817.
Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
ORourke A, White R, Park J, Rodriguez K, Kilkenny M, Sherman S
Harm Reduct J. 2019; 16(1):51.
PMID: 31470864
PMC: 6717345.
DOI: 10.1186/s12954-019-0320-8.
Syringe disposal among people who inject drugs before and after the implementation of a syringe services program.
Levine H, Bartholomew T, Rea-Wilson V, Onugha J, Arriola D, Cardenas G
Drug Alcohol Depend. 2019; 202:13-17.
PMID: 31280002
PMC: 6854527.
DOI: 10.1016/j.drugalcdep.2019.04.025.
Students as effective harm reductionists and needle exchange organizers.
Barbour K, McQuade M, Brown B
Subst Abuse Treat Prev Policy. 2017; 12(1):15.
PMID: 28302153
PMC: 5356241.
DOI: 10.1186/s13011-017-0099-0.
Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.
Cooper H, Des Jarlais D, Ross Z, Tempalski B, Bossak B, Friedman S
J Urban Health. 2012; 89(4):678-96.
PMID: 22585448
PMC: 3535144.
DOI: 10.1007/s11524-012-9673-y.
Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research.
Hyshka E, Strathdee S, Wood E, Kerr T
Int J Drug Policy. 2012; 23(4):261-70.
PMID: 22579215
PMC: 3392518.
DOI: 10.1016/j.drugpo.2012.03.006.
A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.
Tookes H, Kral A, Wenger L, Cardenas G, Martinez A, Sherman R
Drug Alcohol Depend. 2012; 123(1-3):255-9.
PMID: 22209091
PMC: 3358593.
DOI: 10.1016/j.drugalcdep.2011.12.001.
Syringe disposal among injection drug users in San Francisco.
Wenger L, Martinez A, Carpenter L, Geckeler D, Colfax G, Kral A
Am J Public Health. 2010; 101(3):484-6.
PMID: 20466956
PMC: 3036677.
DOI: 10.2105/AJPH.2009.179531.
Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
Rudolph A, Crawford N, Ompad D, Benjamin E, Stern R, Fuller C
J Am Pharm Assoc (2003). 2010; 50(2):140-7.
PMID: 20199954
PMC: 3222463.
DOI: 10.1331/JAPhA.2010.09193.
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
Wood E, Tyndall M, Montaner J, Kerr T
CMAJ. 2006; 175(11):1399-404.
PMID: 17116909
PMC: 1635777.
DOI: 10.1503/cmaj.060863.
The need to promote public health in the field of illicit drug use.
Wainberg M
CMAJ. 2006; 175(11):1395.
PMID: 17116908
PMC: 1635773.
DOI: 10.1503/cmaj.061404.
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.
Santibanez S, Garfein R, Swartzendruber A, Purcell D, Paxton L, Greenberg A
J Urban Health. 2006; 83(1):86-100.
PMID: 16736357
PMC: 2258331.
DOI: 10.1007/s11524-005-9009-2.
Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications.
Qian H, Schumacher J, Chen H, Ruan Y
Harm Reduct J. 2006; 3:4.
PMID: 16451717
PMC: 1402269.
DOI: 10.1186/1477-7517-3-4.
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.
Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D, Montaner J
Harm Reduct J. 2004; 1(1):9.
PMID: 15535885
PMC: 535533.
DOI: 10.1186/1477-7517-1-9.
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.
Wood E, Kerr T, Small W, Li K, Marsh D, Montaner J
CMAJ. 2004; 171(7):731-4.
PMID: 15451834
PMC: 517857.
DOI: 10.1503/cmaj.1040774.